Hi Thip,

I did a little on line research. You really should consult a professional on
mistletoe and find out exactly how to take it. Although this has made some meak
results in certain studies, (and the mistletoe was hightly diluted) you need to
ask a professional on this substance since it it known to be toxic to the
liver. Buying this stuff from a health food store would not benefit you. I must
stress that you would have to see someone who specializes in this type of
therapy before touching it. Here are some studies and risks below.

Effects of a mistletoe preparation with defined lectin content on chronic
hepatitis C: an individually controlled cohort study.

Huber R, Ludtke R, Klassen M, Muller-Buscher G, Wolff-Vorbeck G, Scheer R.

Center for Complementary Medicien, Department of Internal Medicine II,
University Hospital Freiburg, Germany. rhuber@med1.ukl.uni-freiburg.de

Despite advances in the therapy of chronic hepatitis C for some hepatitis C
virus (HCV) genotypes interferon and ribavirin combination therapy is effective
in less than 50% of patients. Abnobaviscum Quercus (AQ) is a mistletoe
preparation containing defined amounts of mistletoe lectins (ML). It has shown
immunomodulatory properties in vitro and in vivo. In small clinical trials AQ
resulted, within an anthroposophical treatment concept, in a biochemical or
virological response in up to 40% of patients with chronic hepatitis C. In
order to evaluate the effect of this preparation we conducted an individually
controlled cohort study. 25 patients with chronic hepatitis C (mean duration
147 +/- 80 months) and elevated alanine aminotransferase (ALT) levels were
included in the study. As control they were observed for 6 months
pre-treatment. This pre-treatment period was followed by 6 months of active
treatment in which the mistletoe preparation was subcutaneously injected three
times a week. Main outcome parameters were normalization of ALT and viral load.
Hepatitis C associated signs and symptoms like tiredness, fullness in the right
upper abdomen and musculoskeletal pain were assessed monthly in a standardized
questionnaire. All 25 patients completed the study and most of the patients
wanted to continue treatment. Mean duration of treatment was 9.1 months. None
of the patients had complete or partial normalization of ALT or HCV RNA levels
during pre-treatment or treatment period. Mean ALT did not change during the
study. Tiredness, fullness in the right upper abdomen and musculoskeletal pain
were present in 18, 8 and 4 patients respectively. They significantly improved
within two months of treatment. A significant eosinophilia (p=0.0001) occurred
between month 2 and 6 during treatment. 9 month treatment with a ML containing
mistletoe preparation has no effect on viral load or ALT as markers of activity
in patients with chronic hepatitis C. However, frequency and intensity of
clinical signs and symptoms in our patients decreased significantly, similar to
reports of improved quality of life in tumour patients treated with such
preparations. A significant eosinophilia suggests that ML containing mistletoe
preparations induce a T-helper 2 immune response.

Publication Types:
Clinical Trial
Controlled Clinical Trial
PMID: 11669085 [PubMed - indexed for MEDLINE]

Government studies Mistletoe:
http://www.clinicaltrials.gov/ct/gui/show/NCT00006354

Ann Emerg Med. 1986 Nov;15(11):1320-3.  Related Articles, Links  

Assessing mistletoe toxicity.

Hall AH, Spoerke DG, Rumack BH.

To assess the potential toxicity of mistletoe ingestion, data were collected on
14 cases of ingestion of one to three berries or one or two leaves of American
mistletoe (Phoradendron sp) from 1982 to 1985. Eleven patients ingested berries
and three ingested leaves; none became symptomatic. Nine patients were observed
at home without intervention except poison center telephone follow-up. Five had
induced emesis, including two who were referred to emergency departments for
evaluation, where no findings other than ipecac-induced vomiting were noted.
Also reviewed were data on a total of 318 cases of mistletoe ingestion reported
to the Food and Drug Administration Poison Control case reporting system
between 1978 and 1983 (n = 177) and the American Association of Poison Control
Centers national data collection system (n = 141) in 1984. The majority
remained asymptomatic and no deaths were recorded. These data allow the
conclusion that ingestion of one to three mistletoe berries or one or two
leaves is unlikely to produce serious toxicity.

PMID: 2877602 [PubMed - indexed for MEDLINE]

So, while it might look alright, it is important to find somebody who knows
about this and how to use it. There are associated serious risks.

Take Care,

Kim